You are here

Article metrics

Article menu

Download PDFPDF

XML
Cardiac risk factors and prevention
Original article
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality

 

Online download statistics by month:

Online download statistics by month: July 2016 to August 2022

AbstractFullPdf
Jul 201642117147
Aug 20161048414209
Sep 201630120277
Oct 20161291243199
Nov 201633265098
Dec 2016184404191
Jan 201712916750
Feb 20171810540
Mar 20171729149
Apr 20171021041
May 2017818629
Jun 20172712430
Jul 201711711526
Aug 20171249917
Sep 20171239819
Oct 2017938921
Nov 20171891619
Dec 201718614718
Jan 201816311815
Feb 201818914215
Mar 201851442230
Apr 201847345930
May 201828624223
Jun 201821119347
Jul 201819414437
Aug 201825724120
Sep 201823822214
Oct 201833331119
Nov 201857337127
Dec 201836834816
Jan 201932225525
Feb 201923921725
Mar 201914410817
Apr 20191387624
May 201915912040
Jun 2019997524
Jul 2019825512
Aug 201912710120
Sep 20191149217
Oct 20191059510
Nov 20191799921
Dec 2019867614
Jan 2020917825
Feb 20201419420
Mar 202016716420
Apr 2020807417
May 2020615715
Jun 2020514013
Jul 2020454233
Aug 202031429122
Sep 2020743512
Oct 2020945217
Nov 20201015528
Dec 2020914910
Jan 20211047322
Feb 2021956315
Mar 20211087615
Apr 202123519222
May 2021826821
Jun 2021595919
Jul 2021434314
Aug 2021666620
Sep 2021555517
Oct 2021926032
Nov 202113610124
Dec 20211258621
Jan 2022100525
Feb 20221548524
Mar 20221268224
Apr 202231513121
May 20222037127
Jun 20221458519
Jul 20221434710
Aug 2022956616
Total14002110502332